Former Sri Lanka player and coach Nuwan Zoysa has been banned from all cricket for six years after an ICC Anti-Corruption Tribunal found him guilty of breaching the ICC Anti-Corruption Code, an ICC release suggests. The ban for Zoysa is backdated to 31 October 2018, when he was provisionally suspended.
The release read, “Following full hearings and presentations of written and oral argument, the Tribunal found Mr Zoysa guilty of:
Kuwait on Saturday suspended all direct commercial flights coming from India until further notice due to the worsening COVID-19 situation in the country. The move came after instructions from health authorities.
Kuwait’s directorate general of civil aviation said that it had suspended all direct commercial flights coming from India, effective April 24. All passengers arriving from India either directly or via another country will be banned from entering unless they have spent at least 14 days out of India, it said in a statement on Twitter.
Kuwaiti citizens, their first degree relatives and their domestic workers will be allowed to enter the country. Operations of freight flights will continue, it said.
Over one million Indian community members live in Kuwait, the largest expatriate community in the country, according to the Indian Embassy in Kuwait. Earlier, the UK, the UAE and Canada announced ban flights from India amid the worsening COVID-19 situation in the country.
A record single-day rise of 3,46,786 coronavirus cases pushed India’s tally of infection to 1,66,10,481, while active cases crossed the 25-lakh mark, according to the Union Health Ministry data updated on Saturday. Meanwhile, the UAE on Friday updated its travel ban for India, saying that all incoming flights on national and foreign carriers from the country will be suspended, while transportation of passengers from the Gulf country to India will be allowed.
The UAE on Thursday banned travel from India for 10 days from Sunday due to the worsening COVID-19 situation in the country. The UAE’s General Authority of Civil Aviation and the National Emergency, Crisis and Disaster Management Authority (NCEMA) announced an update on regulations with the clarification that entry from India will be suspended for all incoming flights on national and foreign carriers.
According to a statement released, this will also apply to those carrying transit passengers, except for transit flights coming to the UAE and heading onward to India. This decision includes the entry of travellers who were in India in the last 14 days prior to coming to the UAE, the statement said.
The statement, however, said that the flights between the two countries will continue to operate allowing the transportation of passengers from the UAE to India. It will also allow the transfer of exempted groups from India to the UAE with the application of the aforementioned precautionary measures. These groups include UAE citizens, diplomatic missions appointed by the two countries, official delegations and those holding golden residency, it said.
The exemptions will apply provided they undertake preventive measures that include quarantine for 10 days and a PCR test at the airport, as well as on the fourth and eighth days following the entry into the country. The required PCR test period has also been reduced from 72 hours to 48 hours prior to travel from accredited laboratories that issue test results carrying a QR code.
The authority also confirmed that it is required for those coming from India through other countries to stay in those countries for at least 14 days before being allowed to enter the country, starting from 23:59 on Saturday, April 24, 2021, said the statement. These regulations will apply for a period of 10 days, which can be extended, while cargo flights continue to operate between the two countries.
The authority called upon all travellers affected by the decision to follow up with the relevant airlines to change or reschedule their flights and to ensure their safe return to their final destinations without delay.
Singapore health ministry said on Thursday it will not allow entry to long-term visa holders and short-term visitors with recent travel history to India, which is battling a second wave of COVID-19 infections.
On Thursday, Singapore said it was investigating COVID-19 cases in a migrant workers’ dormitory for the possibility of re-infection and is quarantining more than 1,100 of the facility’s residents. So far, 17 recovered workers were found to be positive for COVID-19 at the dormitory.
The government said travel restrictions with India will help curb potential cases in the dormitories because many of the labourers arrive from the South Asian nation.
India is hopeful the United States will soon lift a ban on vaccine raw materials that has threatened to slow output of shots in the country, two Indian sources told Reuters on Monday, after the foreign ministers of the two nations spoke.
One of the officials said the administration of President Joe Biden had told India that its request was being considered and would be acted upon “at the earliest”.
External Affairs Ministry said it did not have anything more to add than Foreign Minister S Jaishankar’s tweet that he and US Secretary of State Antony Blinken had discussed, among other things, “issues pertaining to our health cooperation”.
The White House has invoked the wartime powers of the Defense Production Act to preserve vaccine raw materials for its own companies, but the Serum Institute of India (SII), the world’s biggest vaccine maker, has said this went against the global goal of sharing vaccines equitably.
India is currently facing the world’s worst surge in coronavirus infections, which has led to a clamour for vaccines. India, with the world’s biggest vaccine-making capacity, has also stopped major vaccine exports to meet local demand.
The potential movement on raw materials comes days after the SII chief executive tweeted directly to Biden to end the supply curb.
“US needs to lift restrictions for APIs without which there cannot be vaccines for all,” said one of the sources, referring to active pharmaceutical ingredients.
SII is licensed to make the AstraZeneca shot as well another developed by US company Novavax.
The US embassy in New Delhi and SII did not immediately respond to requests for comment outside regular business hours.